Corrigendum to "Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy" [Heliyon Volume 9, Issue 10, October 2023, Article e20903]

E Monteagudo-Gimeno^{1

2}, R Sánchez-González^{3

4}, J Raduà-Castaño^{5

6

7

8

9}, L Fortea-González^{5

7

10}, T Boget-Llucià^{5

10

11}, M Carreño-Martínez^{5

10

11}, A Donaire-Pedraza^{5

10

11}, N Bargalló-Alabart^{5

11}, X Setoain-Perego^{5

10

11

12}, J Rumià-Arboix^{10

11}, A Bulbena-Vilarrasa^{1

3}, L Pintor-Pérez^{5

10

13}

Affiliations

¹ Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Bellaterra, Spain.
² Benito Menni Mental Health Care Complex, Sant Boi de Llobregat, Barcelona, Spain.
³ Department of Psychiatry, Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, Barcelona, Spain.
⁴ IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
⁵ Biomedical Research Institute August Pi i Sunyer (IDIBAPS), Hospital Clinic of Barcelona, Barcelona, Spain.
⁶ FIDMAG Research Foundation, Sant Boi de Llobregat, Barcelona, Spain.
⁷ Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
⁸ Centre for Psychiatric Research and Education, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
⁹ Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
¹⁰ Clinical Institute of Neurosciences, Hospital Clinic of Barcelona, Barcelona, Spain.
¹¹ Epilepsy Unit, Neurology Department, Hospital Clinic of Barcelona, Barcelona, Spain.
¹² Biomedical Imaging Group, Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain.
¹³ Consultation-Liaison Service, Department of Psychiatry, Institut de Neurociències, Universitat de Barcelona, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain.

PMID: 40535898
PMCID: PMC12169289
DOI: 10.1016/j.heliyon.2025.e43194

Published Erratum

Corrigendum to "Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy" [Heliyon Volume 9, Issue 10, October 2023, Article e20903]

E Monteagudo-Gimeno et al. Heliyon. 2025.

. 2025 May 23;11(10):e43194.

doi: 10.1016/j.heliyon.2025.e43194. eCollection 2025 May.

Authors

Affiliations

¹ Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Bellaterra, Spain.
² Benito Menni Mental Health Care Complex, Sant Boi de Llobregat, Barcelona, Spain.
³ Department of Psychiatry, Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, Barcelona, Spain.
⁴ IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
⁵ Biomedical Research Institute August Pi i Sunyer (IDIBAPS), Hospital Clinic of Barcelona, Barcelona, Spain.
⁶ FIDMAG Research Foundation, Sant Boi de Llobregat, Barcelona, Spain.
⁷ Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
⁸ Centre for Psychiatric Research and Education, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
⁹ Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
¹⁰ Clinical Institute of Neurosciences, Hospital Clinic of Barcelona, Barcelona, Spain.
¹¹ Epilepsy Unit, Neurology Department, Hospital Clinic of Barcelona, Barcelona, Spain.
¹² Biomedical Imaging Group, Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain.
¹³ Consultation-Liaison Service, Department of Psychiatry, Institut de Neurociències, Universitat de Barcelona, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain.

PMID: 40535898
PMCID: PMC12169289
DOI: 10.1016/j.heliyon.2025.e43194

Abstract

[This corrects the article DOI: 10.1016/j.heliyon.2023.e20903.].

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Erratum for

Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy.
Monteagudo-Gimeno E, Sánchez-González R, Raduà-Castaño J, Fortea-González L, Boget-Llucià T, Carreño-Martínez M, Donaire-Pedraza A, Bargalló-Alabart N, Setoain-Perego X, Rumià-Arboix J, Bulbena-Vilarrasa A, Pintor-Pérez L. Monteagudo-Gimeno E, et al. Heliyon. 2023 Oct 14;9(10):e20903. doi: 10.1016/j.heliyon.2023.e20903. eCollection 2023 Oct. Heliyon. 2023. PMID: 37886767 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to "Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy" [Heliyon Volume 9, Issue 10, October 2023, Article e20903]

Affiliations

Corrigendum to "Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy" [Heliyon Volume 9, Issue 10, October 2023, Article e20903]

Authors

Affiliations

Abstract

Conflict of interest statement

Erratum for

Publication types

LinkOut - more resources

Full Text Sources